2008
DOI: 10.1086/588587
|View full text |Cite
|
Sign up to set email alerts
|

Whole-Blood Interferon-Gamma Release Assay for Baseline Tuberculosis Screening of Healthcare Workers at a Swiss University Hospital

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
13
0
1

Year Published

2009
2009
2014
2014

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 5 publications
2
13
0
1
Order By: Relevance
“…Moreover, QFT-GIT positive results were higher among HCWs in direct contact with TB patients, as what was reported in Stebler et al (2008) and Mirtskhulava et al (2008) studies.…”
Section: Discussionsupporting
confidence: 79%
See 1 more Smart Citation
“…Moreover, QFT-GIT positive results were higher among HCWs in direct contact with TB patients, as what was reported in Stebler et al (2008) and Mirtskhulava et al (2008) studies.…”
Section: Discussionsupporting
confidence: 79%
“…The rate of detection of LTBI assessed by QFT-GIT in our study was 36%. Low detection rates by QFT-GIT as compared to TST were also reported by other scientists: Harada et al (2006), Soborg et al (2007), Niehaus et al(2008a), Stebler et al (2008) and Ringshausen et al, (2009).…”
Section: Discussionsupporting
confidence: 69%
“…Routine TB screening for HCW is considered as a cornerstone for preventing TB in hospitals and it is performed in many highincome countries, for example, USA [9], Japan [21], France [22], Spain [23] and Switzerland [24]. In the UK, TB screening of HCW is mainly performed as a pre-employment screening [25].…”
Section: Tb Screening For Hcwmentioning
confidence: 99%
“…The net result of functional T-cell signatures would be detectable by assessing the M. tuberculosisspecific IL-2/IFN-␥ ratio in QFT test plasma supernatants. Thus, the simultaneous analysis of both IFN-␥ and IL-2 in QFT test plasma supernatants might provide (i) a more precise basis for assessing an individual's risk of developing active TB disease and (ii) information concerning the interpretation and clinical significance of weakly positive QFT test results (IFN-␥, Ն0.35 to Ͻ1.0 IU/ml), which, in our program (11), make up almost 50% of all positive IGRA results. The QFT assay was performed according to the manufacturer's instructions.…”
mentioning
confidence: 99%